Working… Menu
Trial record 28 of 31 for:    Developmental Disabilities | ( Map: Alabama, United States )

A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03158285
Recruitment Status : Active, not recruiting
First Posted : May 18, 2017
Last Update Posted : August 9, 2019
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 25, 2019
Estimated Study Completion Date : December 8, 2020